Lifeng Sun - Publications

Cross-host transmission of Riemerella anatipestifer to chickens: Genomic evolution and identification of the novel vapX-like-vapD toxin-antitoxin system.

Journal: Virulence

Published: July 30, 2026

Prognostic Factors and Nomogram-Based Prediction Models for Colorectal Cancer Patients With Synchronous Peritoneal Metastasis Undergoing Cytoreductive Surgery: A Retrospective Cohort Study.

Journal: Cancer medicine

Published: August 11, 2025

The heterogeneity of genomic alterations, metastatic patterns and immune microenvironment in metastatic ovarian cancer originating from colorectal cancer.

Journal: Frontiers in immunology

Published: March 14, 2025

Recurrence Prediction by Multi-Omics in the Patient with Colorectal Peritoneal Metastases After Cytoreductive Surgery: A Prospective Biomarker Study.

Journal: Cancer management and research

Published: January 31, 2025

Reply to: Unveiling controversies: The role of HIPEC in colorectal cancer peritoneal metastasis.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: April 09, 2024

Laparoscopic ileocecal-sparing vs traditional right hemicolectomy for cancer of the hepatic flexure or proximal transverse colon: a dual-center propensity score-matched study.

Journal: Gastroenterology report

Published: October 31, 2023

Deep mutational scanning of influenza A virus neuraminidase facilitates the identification of drug resistance mutations in vivo.

Journal: mSystems

Published: September 29, 2023

Prophylactic hyperthermic intraperitoneal chemotherapy in T4 colorectal cancer: Can it improve the oncologic prognosis? - A propensity score matching study.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: July 27, 2023

Feasibility and safety of hybrid transvaginal natural orifice transluminal endoscopic surgery for colon cancer: Protocol for a multicenter, single-arm, phase II trial (vNOTESCA).

Journal: Heliyon

Published: May 06, 2023

Sintilimab plus bevacizumab, oxaliplatin and capecitabine as first-line therapy in RAS-mutant, microsatellite stable, unresectable metastatic colorectal cancer: an open-label, single-arm, phase II trial.

Journal: EClinicalMedicine

Published: April 11, 2023

Sintilimab plus bevacizumab and CapeOx (BBCAPX) on first-line treatment in patients with RAS mutant, microsatellite stable, metastatic colorectal cancer: study protocol of a randomized, open-label, multicentric study.

Journal: BMC cancer

Published: March 07, 2023

Efficacy and safety of ripretinib in Chinese patients with advanced gastrointestinal stromal tumors: a real-world, multicenter, observational study.

Journal: Frontiers in oncology

Published: March 06, 2023